Streetbeat News

Products Services

IONQ

IonQ (NYSE:IONQ) has partnered with Switzerland-based QuantumBasel to establish a European quantum data center, bringing two IonQ quantum systems to the region. IonQ will also set up a quantum innovation center at the uptownBasel campus in Arlesheim, Switzerland, to serve the EMEA region.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:06 pm

BMRN

BioMarin Pharmaceutical (BMRN) will present data from the longest and largest hemophilia gene therapy clinical trial program, ROCTAVIAN, at the International Society on Thrombosis and Haemostasis 2023 Congress.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:05 pm

BOF

BranchOut Food Inc. (NASDAQ:BOF) announces a strategic collaboration with the U.S. Army Combat Capabilities Development Command (DEVCOM) to enhance Meals Ready-to-Eat (MREs) using its proprietary GentleDry technology. The technology surpasses freeze-drying methods in nutritional content retention, flavor, and color preservation.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:05 pm

HZNP

Horizon Therapeutics reports positive topline data from Phase 3 clinical trial (OPTIC-J) in Japan for TEPEZZA (teprotumumab-trbw) in treating active thyroid eye disease (TED). At week 24, 89% of patients treated with TEPEZZA showed clinically meaningful improvement compared to 11% receiving placebo.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 12:05 pm

APM

Aptorum Group has submitted the Phase 1b/2a clinical trial protocol of SACT-1, an orally administered repurposed small molecule drug for the treatment of neuroblastoma, to the US FDA. The trial will study SACT-1 in combination with chemotherapy for first relapse or refractory high-risk neuroblastoma patients.

Portfolio Pulse from Happy Mohamed

June 22, 2023 | 12:04 pm

LIFE

The European Commission has granted Orphan Drug Designation to aTyr Pharma's Efzofitimod for the treatment of systemic sclerosis. This designation provides regulatory and financial incentives for the development of the drug.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:04 pm

JSPR

Jasper Therapeutics has announced the dosing of the first patient in a Phase 1 trial of Briquilimab for lower-risk myelodysplastic syndrome. This marks a significant milestone for the company's clinical development program.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:03 pm

CDTX

Cidara Therapeutics has received FDA Fast Track designation for its novel drug-Fc conjugate, CD388, targeting Influenza A and B. This designation will expedite the development and review process for the drug.

Portfolio Pulse from Bill Haddad

June 22, 2023 | 12:01 pm

AAPL

Apple has fixed two security faults in iPhones and iPads that compromised thousands of devices in Russia. The company credited Kaspersky Lab for discovering the glitches. The fixes protect iPhones running iOS 15.7 or earlier, while more recent versions are already impervious to the attacks.

Portfolio Pulse from Anusuya Lahiri

June 22, 2023 | 11:55 am

QCOM

Qualcomm Technologies announced the launch of two modem chipsets with satellite capability, the Qualcomm 212S Modem and the Qualcomm 9205S Modem. These chipsets enable IoT enterprises, developers, ODMs, and OEMs to manage business projects using real-time information and insights.

Portfolio Pulse from Charles Gross

June 22, 2023 | 11:50 am